China BCT Announces Conference Call to Discuss Third Quarter and
Nine Month FY2012 Results
LIUZHOU, China, Nov. 13, 2012 /PRNewswire/ -- China BCT Pharmacy
Group, Inc., (OTC BB: CNBI), ("China BCT" or the "Company"), a
leading pharmaceutical distributor, retail pharmacy, and
manufacturer of pharmaceutical products in Guangxi Province, China, today announced that it will conduct a
conference call at 8:00 a.m. Eastern
Time on Wednesday, November 14,
2012 to discuss its third quarter and nine month FY2012
results.
Mr. Huitian Tang, Chief Executive
Officer of the Company, and Ms. Shelly
Zhang, Chief Financial Officer of the Company, will host the
conference call. The Company will release its financial results for
the third quarter and nine months to September 30, 2012 prior to the call.
The conference call can be accessed by dialing 866-759-2078
(U.S. and Canada callers) or
706-643-0585 (international callers) and entering the conference ID
70856824 approximately five to ten minutes prior to the call. A
replay will be available for two weeks starting on Wednesday, November 14, 2012 at 11:00 a.m. ET by dialing 855-859-2056 (U.S. and
Canada callers) or 404-537-3406
(international callers) and entering the conference replay ID
70856824.
About China BCT
China BCT is engaged in pharmaceutical distribution, pharmacy
retailing, and the manufacture of pharmaceuticals products through
its subsidiaries Guangxi Liuzhou Baicaotang Medicine Limited,
Guangxi Liuzhou Baicaotang Medicine Retail Limited, and Hefeng
Pharmaceutical Co. Limited in Guangxi province, China. It operates a large regional retail
network in Guangxi province,
consisting of 195 directly owned retail stores in Guangxi province and currently over 8,000
products are distributed through the Company's wholesale
distribution network. For more information, please visit
www.china-bct.com.
Company Contact:
Ms. Shelly Zhang, Chief Financial
Officer
China BCT Pharmacy Group, Inc.
Email: shelly.zhang@china-bct.com
Tel: +86-772-363-8318
Website: www.china-bct.com
Investor Relations Contact:
Mark Collinson, Partner
CCG Investor Relations
Email: mark.collinson@ccgir.com
Tel: +1-310-954-1343
www.ccgirasia.com
SOURCE China BCT Pharmacy Group, Inc.